Polyganglionitis

Polyganglionitis is a disease that involves damage and inflammation of the peripheral nerves connected to the brain and nerves in the head. This condition can lead to pain and changes in how the body functions.

Polyganglionitis usually occurs in people between 50 and 60 years of age and is most often associated with a number of causes, such as head trauma, brain surgery, stroke or brain infection.

Unfortunately, polyganglionitis is not treated with traditional treatment, since it is a complication of the underlying disease. However, doctors may prescribe additional medications to reduce symptoms and improve patients' quality of life.

One of the most well-known polyganglionitis is Multiple Sclerosis, a disease in which inflammation is dispersed throughout the brain and spinal cord. Treatment for multiple sclerosis aims to reduce symptoms and improve patients' quality of life, but there is no known way to prevent or stop the progression of the disease.

Other known polyganglia, such as Guillain-Barré syndrome and Lesch-Nyhan syndrome, also have similar characteristics and symptoms that need to be treated differently.

Polyganglionic

Polyganglia (polyganglionic) are malignant diseases of the peripheral paraganglia and sympathetic ganglia. Usually about 30% of people are affected and those suffering from this disease most often live no more than 5 years. Metastasis of this disease is less common. Oral cavity, larynx, upper respiratory tract, torso, muscles of the anterior abdominal wall, etc. are the site of localization of metastases. The risk of incidence of polygangleonic disease is 1% in men and 3% in women. In childhood, this disease mainly affects boys. Currently, about 1 person is affected by this disease.